MedTrace Logo

Development and Validation of a Driving Simulator for Evaluating the Residual Effects of Drugs on Driving Performance - Sensitivity Analysis Using Zopiclone As a Positive Control

NCT04108351 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2025-02-28

No results posted yet for this study

Summary

The purpose of this study is to confirm of assay sensitivity of Driving Simulator by positive control

Conditions

  • Healthy Participants

Interventions

OTHER

Road-tracking test

Driving with simulator program for SDLP measurement

OTHER

Car-following test

Intervention Description: Driving with simulator program for DCV measurement

OTHER

Harsh-braking test

Driving with simulator program for BRT measurement

Sponsors & Collaborators

  • Nagoya University

    collaborator OTHER

  • Taisho Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Taisho Director · Taisho Pharmaceutical Co., Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
64 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-07
Primary Completion
2020-02-11
Completion
2020-02-11

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04108351 on ClinicalTrials.gov